Kite Pharma, Inc.
Aug 14, 2015

Kite Pharma to Hold Conference Call to Provide a Corporate Update on Monday, August 17, 2015

SANTA MONICA, Calif., Aug. 14, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Kite) (Nasdaq:KITE) today announced that it will host a live conference call on Monday, August 17, 2015, at 9:00am Eastern Time to provide a corporate update.

The live webcast and subsequent replay may be accessed by visiting the Company's website at ir.kitepharma.com. Please connect to the Company's website at least 5-10 minutes prior to the live webcast to ensure adequate time for any necessary software download. Alternatively, please call (844) 856-8656 (U.S.) or (443) 877-4062 (international) to listen to the live conference call. The conference ID number for the live call is 15633524. Please dial in approximately 10 minutes prior to the call. The webcast will be available on the Company's website for two weeks following the call. 

About Kite Pharma, Inc.

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous T-cell (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA.

CONTACT: Kite Pharma

         Cynthia M. Butitta

         Chief Financial Officer and Chief Operating Officer

         310-824-9999



         For Media: Justin Jackson

         For Investor Inquiries: Lisa Burns and Carol Werther

         Burns McClellan

         212-213-0006

         jjackson@burnsmc.com

         lburns@burnsmc.com

         cwerther@burnsmc.com

Kite Pharma, Inc. logo

Source: Kite Pharma, Inc.

News Provided by Acquire Media